Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 3
1993 1
1994 3
1995 1
1996 1
1997 3
1998 5
1999 6
2000 3
2001 3
2002 5
2003 4
2004 4
2005 2
2006 1
2007 2
2008 16
2009 14
2010 18
2011 13
2012 17
2013 12
2014 4
2015 6
2016 10
2017 13
2018 7
2019 6
2020 4
2021 3
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
New approaches in psychiatric drug development.
van der Doef TF, Zaragoza Domingo S, Jacobs GE, Drevets WC, Marston HM, Nathan PJ, Tome MB, Tamminga CA, van Gerven JMA, Kas MJH. van der Doef TF, et al. Among authors: van gerven jma. Eur Neuropsychopharmacol. 2018 Sep;28(9):983-993. doi: 10.1016/j.euroneuro.2018.06.006. Epub 2018 Jul 25. Eur Neuropsychopharmacol. 2018. PMID: 30056086 Review.
MDMA study.
Gijsman HJ, Verkes RJ, van Gerven JM, Cohen AF. Gijsman HJ, et al. Among authors: van gerven jm. Neuropsychopharmacology. 1999 Oct;21(4):597. doi: 10.1016/S0893-133X(99)00021-4. Neuropsychopharmacology. 1999. PMID: 10481843 No abstract available.
The use of biomarkers in human pharmacology (Phase I) studies.
Cohen AF, Burggraaf J, van Gerven JM, Moerland M, Groeneveld GJ. Cohen AF, et al. Among authors: van gerven jm. Annu Rev Pharmacol Toxicol. 2015;55:55-74. doi: 10.1146/annurev-pharmtox-011613-135918. Epub 2014 Oct 6. Annu Rev Pharmacol Toxicol. 2015. PMID: 25292425 Review.
[Current and future therapeutic options for COVID-19].
Dankers M, Nelissen-Vrancken HMJMG, Berger MY, Bonten MJM, van Gerven JMA, Kunst PWA, Muller M, Olde Rikkert MGM, Rosendaal FR. Dankers M, et al. Among authors: van gerven jma. Ned Tijdschr Geneeskd. 2022 Jul 21;166:D6675. Ned Tijdschr Geneeskd. 2022. PMID: 36036702 Dutch.
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder.
Recourt K, de Boer P, van der Ark P, Benes H, van Gerven JMA, Ceusters M, van Nueten L, Drevets WC, Bhatacharya A, Browning M, Jacobs GE. Recourt K, et al. Among authors: van gerven jma. Transl Psychiatry. 2023 Jul 24;13(1):266. doi: 10.1038/s41398-023-02557-5. Transl Psychiatry. 2023. PMID: 37482560 Free PMC article. Clinical Trial.
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs.
Ferreira GS, Dijkstra FM, Veening-Griffioen DH, Boon WPC, Schellekens H, Moors EHM, van Meer PJK, Stuurman FE, van Gerven JMA. Ferreira GS, et al. Among authors: van gerven jma. Transl Psychiatry. 2023 Mar 1;13(1):74. doi: 10.1038/s41398-023-02353-1. Transl Psychiatry. 2023. PMID: 36859342 Free PMC article. Review.
Biomarkers for the effects of benzodiazepines in healthy volunteers.
de Visser SJ, van der Post JP, de Waal PP, Cornet F, Cohen AF, van Gerven JM. de Visser SJ, et al. Among authors: van gerven jm. Br J Clin Pharmacol. 2003 Jan;55(1):39-50. doi: 10.1046/j.1365-2125.2002.t01-10-01714.x. Br J Clin Pharmacol. 2003. PMID: 12534639 Free PMC article. Review.
159 results